LifeStance Health Group Inc (NASDAQ: LFST) kicked off on Tuesday, up 2.24% from the previous trading day, before settling in for the closing price of $6.71. Over the past 52 weeks, LFST has traded in a range of $4.64-$9.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 51.51% over the past five years. While this was happening, its average annual earnings per share was recorded 52.44%. With a float of $110.97 million, this company’s outstanding shares have now reached $378.73 million.
Let’s look at the performance matrix of the company that is accounted for 9325 employees. In terms of profitability, gross margin is 24.97%, operating margin of -11.93%, and the pretax margin is -13.81%.
LifeStance Health Group Inc (LFST) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Care Facilities Industry. The insider ownership of LifeStance Health Group Inc is 71.00%, while institutional ownership is 32.77%. The most recent insider transaction that took place on Sep 13 ’24, was worth 609,540. Before that another transaction happened on Aug 23 ’24, when Company’s Chief People Officer sold 5,269 for $6.28, making the entire transaction worth $33,089. This insider now owns 263,007 shares in total.
LifeStance Health Group Inc (LFST) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 52.44% per share during the next fiscal year.
LifeStance Health Group Inc (NASDAQ: LFST) Trading Performance Indicators
Take a look at LifeStance Health Group Inc’s (LFST) current performance indicators. Last quarter, stock had a quick ratio of 1.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.40, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.17 in one year’s time.
Technical Analysis of LifeStance Health Group Inc (LFST)
LifeStance Health Group Inc (NASDAQ: LFST) saw its 5-day average volume 0.95 million, a negative change from its year-to-date volume of 1.47 million. As of the previous 9 days, the stock’s Stochastic %D was 27.05%. Additionally, its Average True Range was 0.24.
During the past 100 days, LifeStance Health Group Inc’s (LFST) raw stochastic average was set at 80.14%, which indicates a significant increase from 30.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 29.74% in the past 14 days, which was lower than the 39.80% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.85, while its 200-day Moving Average is $6.28. Nevertheless, the first resistance level for the watch stands at $6.95 in the near term. At $7.04, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.17. If the price goes on to break the first support level at $6.72, it is likely to go to the next support level at $6.59. The third support level lies at $6.50 if the price breaches the second support level.
LifeStance Health Group Inc (NASDAQ: LFST) Key Stats
The company with the Market Capitalisation of 2.62 billion has total of 382,623K Shares Outstanding. Its annual sales at the moment are 1,056 M in contrast with the sum of -186,260 K annual income. Company’s last quarter sales were recorded 312,330 K and last quarter income was -23,280 K.
